Maria Lluch Senar

Company: Pulmobiotics

Job title: Co-Founder & Chief Scientific Officer

Seminars:

Engineering Microbiome-Based Inhaled Therapies for Respiratory Diseases 3:30 pm

Addressing the complexities of selecting the right bacterial chassis for inhaled microbiome-based therapies to prevent rapid clearance by the immune system and respiratory physiology Exploring Pulmobiotics’ approach to engineering bacteria to produce human proteins like cytokines and interleukins to stimulate targeted immune responses in conditions like lung cancer Highlighting Pulmobiotics’ innovative use of microbiome-derived bacteria,…Read more

day: Conference Day 2 - 3-5pm